Tag: PR Newswire

Campaign elevates real stories to spotlight empowerment in knowing early

WASHINGTON, May 13, 2026 /PRNewswire/ — A new awareness campaign, This is ALZ, launched today to challenge long-held perceptions of Alzheimer’s by revealing what the disease looks like in its earlier stages, when symptoms are mild or have yet to show.

Powered by HealthyWomen, the campaign spotlights the lived experiences of people navigating the earlier stages of Alzheimer’s, from those who are cognitively unimpaired and experience no symptoms, to those who are beginning to experience cognitive impairment with more noticeable symptoms.

Alzheimer’s disease affects more than 7 million Americans, nearly two-thirds of whom are women, with older Black and Hispanic Americans facing a higher risk. Despite its prevalence, awareness of the disease’s earlier stages remains limited. Nearly all Americans (99%) say early-stage diagnosis is important, yet fewer than one in five (16%) say they know a lot about Alzheimer’s, highlighting a critical gap that This is ALZ aims to address.

“Alzheimer’s is commonly viewed as a disease that only impacts people in its most advanced stages, but the reality is far more nuanced,” said Beth Battaglino, RN-C, CEO of HealthyWomen. “By sharing real stories from people living with the earlier stages, This is ALZ aims to shift perceptions, encourage earlier conversations and help people better understand what’s possible after diagnosis.”

While Alzheimer’s is often associated with its later stages, it develops over time and can present differently in its earlier stages, when changes may be subtle. This is ALZ highlights a broader view of the disease, including how people living with the earlier stages may continue to maintain independence, connection and a sense of purpose after diagnosis.

“People have that thought that your life ends when you get the diagnosis. But I felt like my life was just beginning,” said LauraLee Denler, who is living with the earlier stages of Alzheimer’s and is helping challenge common assumptions about life after diagnosis.

Redefining What’s Possible

At the heart of the campaign are personal stories that challenge stigma and outdated assumptions about Alzheimer’s, demonstrating that people can continue to lead meaningful, engaged lives in the earlier stages of the disease.

“My story is very different. People don’t really get that I have Alzheimer’s. They see me as kind of young,” said Pako Rios, who is living with the earlier stages of Alzheimer’s and whose experience reflects how the disease can largely remain outwardly invisible in its earlier stages.

Highlighting a New Era of Understanding

Advances in research, diagnosis and treatment are transforming how Alzheimer’s is understood and managed. New diagnostic tools, including U.S. Food and Drug Administration (FDA)-cleared blood-tests, are making it possible to identify the disease earlier than ever before.

Knowing Early Can Help People Live Intentionally

A key message of This is ALZ is that those who know early are taking action and changing what’s possible with their lives. Early awareness can provide individuals and families with time to plan, make informed decisions and focus on what matters most, from health and wellness to care and financial planning. It can also open the door to meaningful conversations and stronger support systems.

“By being diagnosed early, I have a lot more opportunities. It gave me the chance to make decisions about how I want to live my life,” said Kerry Dennis, who is living with the earlier stages of Alzheimer’s and emphasizes how early awareness can support more intentional decision-making.

“Alzheimer’s is too often recognized only in its later stages, leaving many individuals and families without the information they need early on,” said Karyne Jones, President and CEO of NCBA. “Campaigns like This is ALZ are critical to broadening awareness, especially in communities like ours where greater understanding of the earlier stages of Alzheimer’s is needed. By elevating real stories and emphasizing the importance of knowing early, we can help reduce stigma, encourage timely conversations and ensure individuals and families are better equipped to plan, seek care and continue living with purpose.”

Turning Awareness Into Action
By elevating real stories, This is ALZ encourages the public, policymakers and healthcare decision makers to reconsider assumptions about Alzheimer’s and recognize the value of early diagnosis.

This is ALZ is supported by a multi-channel effort to drive awareness and engagement, including the launch of a new website and social channels, advertising, partner outreach, signature story videos, blog content and other educational resources to help increase understanding of the earlier stages of Alzheimer’s.

To learn more and explore stories from those living with the earlier stages of Alzheimer’s, visit ThisisALZ.com.

About This is ALZ
This is ALZ is a campaign that highlights the real experiences of people living with the earlier stages of Alzheimer’s. By sharing personal stories, the campaign shows that the disease is just one part of an individual’s story and underscores how knowing early can empower people to live intentionally now and into the future. This is ALZ is powered by HealthyWomen. Learn more at ThisisALZ.com. Follow This is ALZ on social at @thisisalzvoices.

About HealthyWomen
HealthyWomen is the nation’s leading independent, nonprofit health information source for women. HealthyWomen.org was the first website to comprehensively address women’s health and wellness issues and continues to educate women to make informed health decisions by providing objective, fact-based information. For nearly 40 years, women have turned to HealthyWomen for answers to their most important healthcare questions. To learn more, please visit www.HealthyWomen.org. Follow HealthyWomen on Facebook, Twitter, Instagram and LinkedIn.

HealthyWomen developed this initiative with support from and in collaboration with Eli Lilly (Lilly) and Company.

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-this-is-alz-campaign-puts-a-face-to-the-earlier-stages-of-alzheimers-and-expands-understanding-of-the-disease-302770964.html

SOURCE This is ALZ

Campaign elevates real stories to spotlight empowerment in knowing early

WASHINGTON, May 13, 2026 /PRNewswire/ — A new awareness campaign, This is ALZ, launched today to challenge long-held perceptions of Alzheimer’s by revealing what the disease looks like in its earlier stages, when symptoms are mild or have yet to show.

Powered by HealthyWomen, the campaign spotlights the lived experiences of people navigating the earlier stages of Alzheimer’s, from those who are cognitively unimpaired and experience no symptoms, to those who are beginning to experience cognitive impairment with more noticeable symptoms.

Alzheimer’s disease affects more than 7 million Americans, nearly two-thirds of whom are women, with older Black and Hispanic Americans facing a higher risk. Despite its prevalence, awareness of the disease’s earlier stages remains limited. Nearly all Americans (99%) say early-stage diagnosis is important, yet fewer than one in five (16%) say they know a lot about Alzheimer’s, highlighting a critical gap that This is ALZ aims to address.

“Alzheimer’s is commonly viewed as a disease that only impacts people in its most advanced stages, but the reality is far more nuanced,” said Beth Battaglino, RN-C, CEO of HealthyWomen. “By sharing real stories from people living with the earlier stages, This is ALZ aims to shift perceptions, encourage earlier conversations and help people better understand what’s possible after diagnosis.”

While Alzheimer’s is often associated with its later stages, it develops over time and can present differently in its earlier stages, when changes may be subtle. This is ALZ highlights a broader view of the disease, including how people living with the earlier stages may continue to maintain independence, connection and a sense of purpose after diagnosis.

“People have that thought that your life ends when you get the diagnosis. But I felt like my life was just beginning,” said LauraLee Denler, who is living with the earlier stages of Alzheimer’s and is helping challenge common assumptions about life after diagnosis.

Redefining What’s Possible

At the heart of the campaign are personal stories that challenge stigma and outdated assumptions about Alzheimer’s, demonstrating that people can continue to lead meaningful, engaged lives in the earlier stages of the disease.

“My story is very different. People don’t really get that I have Alzheimer’s. They see me as kind of young,” said Pako Rios, who is living with the earlier stages of Alzheimer’s and whose experience reflects how the disease can largely remain outwardly invisible in its earlier stages.

Highlighting a New Era of Understanding

Advances in research, diagnosis and treatment are transforming how Alzheimer’s is understood and managed. New diagnostic tools, including U.S. Food and Drug Administration (FDA)-cleared blood-tests, are making it possible to identify the disease earlier than ever before.

Knowing Early Can Help People Live Intentionally

A key message of This is ALZ is that those who know early are taking action and changing what’s possible with their lives. Early awareness can provide individuals and families with time to plan, make informed decisions and focus on what matters most, from health and wellness to care and financial planning. It can also open the door to meaningful conversations and stronger support systems.

“By being diagnosed early, I have a lot more opportunities. It gave me the chance to make decisions about how I want to live my life,” said Kerry Dennis, who is living with the earlier stages of Alzheimer’s and emphasizes how early awareness can support more intentional decision-making.

“Alzheimer’s is too often recognized only in its later stages, leaving many individuals and families without the information they need early on,” said Karyne Jones, President and CEO of NCBA. “Campaigns like This is ALZ are critical to broadening awareness, especially in communities like ours where greater understanding of the earlier stages of Alzheimer’s is needed. By elevating real stories and emphasizing the importance of knowing early, we can help reduce stigma, encourage timely conversations and ensure individuals and families are better equipped to plan, seek care and continue living with purpose.”

Turning Awareness Into Action
By elevating real stories, This is ALZ encourages the public, policymakers and healthcare decision makers to reconsider assumptions about Alzheimer’s and recognize the value of early diagnosis.

This is ALZ is supported by a multi-channel effort to drive awareness and engagement, including the launch of a new website and social channels, advertising, partner outreach, signature story videos, blog content and other educational resources to help increase understanding of the earlier stages of Alzheimer’s.

To learn more and explore stories from those living with the earlier stages of Alzheimer’s, visit ThisisALZ.com.

About This is ALZ
This is ALZ is a campaign that highlights the real experiences of people living with the earlier stages of Alzheimer’s. By sharing personal stories, the campaign shows that the disease is just one part of an individual’s story and underscores how knowing early can empower people to live intentionally now and into the future. This is ALZ is powered by HealthyWomen. Learn more at ThisisALZ.com. Follow This is ALZ on social at @thisisalzvoices.

About HealthyWomen
HealthyWomen is the nation’s leading independent, nonprofit health information source for women. HealthyWomen.org was the first website to comprehensively address women’s health and wellness issues and continues to educate women to make informed health decisions by providing objective, fact-based information. For nearly 40 years, women have turned to HealthyWomen for answers to their most important healthcare questions. To learn more, please visit www.HealthyWomen.org. Follow HealthyWomen on Facebook, Twitter, Instagram and LinkedIn.

HealthyWomen developed this initiative with support from and in collaboration with Eli Lilly (Lilly) and Company.

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-this-is-alz-campaign-puts-a-face-to-the-earlier-stages-of-alzheimers-and-expands-understanding-of-the-disease-302770964.html

SOURCE This is ALZ

SHANGHAI, May 13, 2026 /PRNewswire/ — Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987, “Yum China” or the “Company”) today announced that the Company has continued to be included in the Dow Jones Best-in-Class World Index (DJBIC World, formerly DJSI World) and the Dow Jones Best-in-Class Emerging Markets Index (DJBIC Emerging Markets, formerly DJSI Emerging Markets) for the sixth consecutive year. Notably, Yum China is the only consumer services company from mainland China to be included in the DJBIC World Index. This achievement underscores the Company’s long-standing commitment and leading practices in environmental, social, and governance (ESG).

The Company’s inclusion in the DJBIC indices is driven by its strong performance in the S&P Global Corporate Sustainability Assessment (CSA). Yum China achieved a record-high score of 81 in the 2025 S&P Global CSA, ranking first globally in the Restaurants & Leisure Facilities industry for the sixth consecutive year, and was also named to the S&P Global Sustainability Yearbook. Of the 25 CSA evaluation criteria, Yum China ranked in the top 1% in 13 criteria, and achieved the highest score in the industry in 8 criteria, including Sustainable Raw Materials, Labor Practices, Customer Relations, and Privacy Protection, among others.

Furthermore, Yum China’s outstanding sustainability performance continues to be recognized by other leading ESG agencies. In March 2026, the Company maintained its AA MSCI ESG Rating for the fifth consecutive year, highlighting its continued leadership within the restaurant industry.

Together, these recognitions reflect Yum China’s long-term commitment and continued dedication to sustainability. As Yum China looks ahead, its focus is clear: to grow with purpose, lead with responsibility and create long-term value across its ecosystem. Whether it is safeguarding food safety, empowering its employees, or driving decarbonization across the value chain, the Company strives to strengthen the connection between sustainable development and business performance. This alignment has been and will continue to be a core competitive advantage for Yum China. The Company is confident in its ability to deliver meaningful and lasting impact for its stakeholders and for society.

To learn more about Yum China’s ESG efforts,

please visit: https://www.yumchina.com/sustainability/en/home/Index

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. We intend all forward-looking statements to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts and by the use of forward-looking words such as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,” “intend,” “belief,” “plan,” “estimate,” “target,” “predict,” “project,” “likely,” “will,” “continue,” “should,” “forecast,” “outlook,” “commit” or similar terminology. These statements are based on current estimates and assumptions made by us in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we believe are appropriate and reasonable under the circumstances, but there can be no assurance that such estimates and assumptions will prove to be correct. Forward-looking statements are not guarantees of performance and are inherently subject to known and unknown risks and uncertainties that are difficult to predict and could cause our actual results or events to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or assumptions will be achieved. The forward-looking statements included in this press release are only made as of the date of this press release, and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law. Numerous factors could cause our actual results or events to differ materially from those expressed or implied by forward-looking statements. In addition, other risks and uncertainties not presently known to us or that we currently believe to be immaterial could affect the accuracy of any such forward-looking statements. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. You should consult our filings with the Securities and Exchange Commission (including the information set forth under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q) for additional detail about factors that could affect our financial and other results.

About Yum China Holdings, Inc.

Yum China is the largest restaurant company in China with a mission to make every life taste beautiful. The Company operates over 18,000 restaurants under six brands across over 2,600 cities in China. KFC and Pizza Hut are the leading brands in the quick-service and casual dining restaurant spaces in China, respectively. In addition, Yum China has partnered with Lavazza to develop the Lavazza coffee concept in China. Little Sheep and Huang Ji Huang specialize in Chinese cuisine. Taco Bell offers innovative Mexican-inspired food. Yum China has a world-class, digitalized supply chain which includes an extensive network of logistics centers nationwide and an in-house supply chain management system. Its strong digital capabilities and loyalty program enable the Company to reach customers faster and serve them better. Yum China is a Fortune 500 company with the vision to be the world’s most innovative pioneer in the restaurant industry. For more information, please visit http://ir.yumchina.com.

Contacts

Investor Relations Contact:
Tel: +86 21 2407 7556
IR@YumChina.com

Media Contact:
Tel: +86 21 2407 3824
Media@YumChina.com

 

View original content:https://www.prnewswire.com/news-releases/yum-china-included-in-dow-jones-best-in-class-world-index-formerly-djsi-world-for-the-sixth-consecutive-year-retaining-global-industry-no-1-302770278.html

SOURCE Yum China Holdings, Inc.

SHANGHAI, May 13, 2026 /PRNewswire/ — Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987, “Yum China” or the “Company”) today announced that the Company has continued to be included in the Dow Jones Best-in-Class World Index (DJBIC World, formerly DJSI World) and the Dow Jones Best-in-Class Emerging Markets Index (DJBIC Emerging Markets, formerly DJSI Emerging Markets) for the sixth consecutive year. Notably, Yum China is the only consumer services company from mainland China to be included in the DJBIC World Index. This achievement underscores the Company’s long-standing commitment and leading practices in environmental, social, and governance (ESG).

The Company’s inclusion in the DJBIC indices is driven by its strong performance in the S&P Global Corporate Sustainability Assessment (CSA). Yum China achieved a record-high score of 81 in the 2025 S&P Global CSA, ranking first globally in the Restaurants & Leisure Facilities industry for the sixth consecutive year, and was also named to the S&P Global Sustainability Yearbook. Of the 25 CSA evaluation criteria, Yum China ranked in the top 1% in 13 criteria, and achieved the highest score in the industry in 8 criteria, including Sustainable Raw Materials, Labor Practices, Customer Relations, and Privacy Protection, among others.

Furthermore, Yum China’s outstanding sustainability performance continues to be recognized by other leading ESG agencies. In March 2026, the Company maintained its AA MSCI ESG Rating for the fifth consecutive year, highlighting its continued leadership within the restaurant industry.

Together, these recognitions reflect Yum China’s long-term commitment and continued dedication to sustainability. As Yum China looks ahead, its focus is clear: to grow with purpose, lead with responsibility and create long-term value across its ecosystem. Whether it is safeguarding food safety, empowering its employees, or driving decarbonization across the value chain, the Company strives to strengthen the connection between sustainable development and business performance. This alignment has been and will continue to be a core competitive advantage for Yum China. The Company is confident in its ability to deliver meaningful and lasting impact for its stakeholders and for society.

To learn more about Yum China’s ESG efforts,

please visit: https://www.yumchina.com/sustainability/en/home/Index

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. We intend all forward-looking statements to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts and by the use of forward-looking words such as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,” “intend,” “belief,” “plan,” “estimate,” “target,” “predict,” “project,” “likely,” “will,” “continue,” “should,” “forecast,” “outlook,” “commit” or similar terminology. These statements are based on current estimates and assumptions made by us in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we believe are appropriate and reasonable under the circumstances, but there can be no assurance that such estimates and assumptions will prove to be correct. Forward-looking statements are not guarantees of performance and are inherently subject to known and unknown risks and uncertainties that are difficult to predict and could cause our actual results or events to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or assumptions will be achieved. The forward-looking statements included in this press release are only made as of the date of this press release, and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law. Numerous factors could cause our actual results or events to differ materially from those expressed or implied by forward-looking statements. In addition, other risks and uncertainties not presently known to us or that we currently believe to be immaterial could affect the accuracy of any such forward-looking statements. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. You should consult our filings with the Securities and Exchange Commission (including the information set forth under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q) for additional detail about factors that could affect our financial and other results.

About Yum China Holdings, Inc.

Yum China is the largest restaurant company in China with a mission to make every life taste beautiful. The Company operates over 18,000 restaurants under six brands across over 2,600 cities in China. KFC and Pizza Hut are the leading brands in the quick-service and casual dining restaurant spaces in China, respectively. In addition, Yum China has partnered with Lavazza to develop the Lavazza coffee concept in China. Little Sheep and Huang Ji Huang specialize in Chinese cuisine. Taco Bell offers innovative Mexican-inspired food. Yum China has a world-class, digitalized supply chain which includes an extensive network of logistics centers nationwide and an in-house supply chain management system. Its strong digital capabilities and loyalty program enable the Company to reach customers faster and serve them better. Yum China is a Fortune 500 company with the vision to be the world’s most innovative pioneer in the restaurant industry. For more information, please visit http://ir.yumchina.com.

Contacts

Investor Relations Contact:
Tel: +86 21 2407 7556
IR@YumChina.com

Media Contact:
Tel: +86 21 2407 3824
Media@YumChina.com

 

View original content:https://www.prnewswire.com/news-releases/yum-china-included-in-dow-jones-best-in-class-world-index-formerly-djsi-world-for-the-sixth-consecutive-year-retaining-global-industry-no-1-302770278.html

SOURCE Yum China Holdings, Inc.

MOU supports the commercialization of fusion energy technology

OTTAWA, ON and OXFORD, United Kingdom, May 13, 2026 /PRNewswire/ — Stellarex Energy and the United Kingdom Atomic Energy Authority (UKAEA) are pleased to announce the signing of a Memorandum of Understanding (MOU) to collaborate on the advancement of stellarator fusion energy technology.

This MoU provides a framework for joint scientific research and engineering validation to accelerate the deployment and development of Stellarex’s simplified stellarator fusion power plant design.

The collaboration focuses on critical technical areas required to transition fusion from experimental science to industrial-scale engineering. Under the terms of the MOU, Stellarex and UKAEA will partner on several key initiatives, including plasma physics and confinement, high-temperature superconductors technology, operational systems, diagnostics, and fuel cycle.

“Stellarex is delighted to be collaborating with the UKAEA, an organization at the forefront of the global effort to commercialize fusion energy,” said Dr. Spencer Pitcher, Co-founder and CEO of Stellarex Energy. “By combining our simplified stellarator approach with UKAEA’s unparalleled fusion expertise, we are significantly de-risking the path to a commercially viable fusion power plant.”

Stephen Wheeler, UKAEA Executive Director, said: “UKAEA has decades of experience operating powerful fusion machines and solving complex fusion challenges that are relevant to many different fusion system designs. We are committed to supporting fusion developers around the globe to help develop fusion as a source of clean energy for tomorrow’s power plants.

“There are many innovative approaches to fusion and UKAEA is pleased to work with Stellarex to support the development of stellarator technology.”

About Stellarex Energy

Stellarex Energy is a Princeton University spin-off focused on fusion energy development. By leveraging a simplified stellarator design, Stellarex Energy reduces technical risk and utilizes staged demonstration devices to validate technology, de‑risk scale‑up, and accelerate the commercial and economical deployment of fusion power. Through its strategic partnership with Ontario Power Generation (OPG) and its leadership in the Centre for Fusion Energy – a new Canadian public-private partnership focused on advancing fusion energy research and developing a demonstration reactor – the company is accelerating the deployment of fusion power in Canada. Stellarex Energy is headquartered in Toronto, Canada.

About the United Kingdom Atomic Energy Authority 

The United Kingdom Atomic Energy Authority (UKAEA) is the UK’s national fusion energy research organisation. We are an executive non-departmental public body of the Department for Energy Security and Net Zero (DESNZ). 

The work we do 

UKAEA’s mission is to lead the delivery of sustainable fusion energy to maximise scientific and UK economic benefit. We do this by being technical experts, partnering with companies and the international research community. At the core of UKAEA’s efforts is the operation of world-leading facilities that build a comprehensive knowledge base for fusion energy. By addressing and solving the challenges across the full lifecycle of fusion, and integrating solutions from various disciplines, we establish technical centres of excellence that serve as the foundation for future fusion power plant programmes. UKAEA collaborates with its partners to develop fusion power plants by providing access to our skills, facilities and expertise. UKAEA owns UK Fusion Energy (UKFE) on behalf of the UK government. Through UKFE, we’re spearheading the Spherical Tokamak for Energy Production (STEP) programme to design and build the UK’s first prototype fusion energy power plant in Nottinghamshire. To grow the fusion ecosystem, UKAEA focuses on cultivating skilled talent, growing the fusion industry and creating ‘innovation clusters’. We actively seek opportunities to advance fusion technologies and communicate its vast potential to stakeholders and the public alike to accelerate fusion energy’s future – the energy of tomorrow we need today. 

For further information, please contact:
Stellarex
info@stellarex.energy

UKAEA Media Relations
mediaenquiry@ukaea.uk

View original content to download multimedia:https://www.prnewswire.com/news-releases/ukaea-and-stellarex-energy-to-advance-fusion-power-development-302770709.html

SOURCE Stellarex, Inc.

MOU supports the commercialization of fusion energy technology

OTTAWA, ON and OXFORD, United Kingdom, May 13, 2026 /PRNewswire/ — Stellarex Energy and the United Kingdom Atomic Energy Authority (UKAEA) are pleased to announce the signing of a Memorandum of Understanding (MOU) to collaborate on the advancement of stellarator fusion energy technology.

This MoU provides a framework for joint scientific research and engineering validation to accelerate the deployment and development of Stellarex’s simplified stellarator fusion power plant design.

The collaboration focuses on critical technical areas required to transition fusion from experimental science to industrial-scale engineering. Under the terms of the MOU, Stellarex and UKAEA will partner on several key initiatives, including plasma physics and confinement, high-temperature superconductors technology, operational systems, diagnostics, and fuel cycle.

“Stellarex is delighted to be collaborating with the UKAEA, an organization at the forefront of the global effort to commercialize fusion energy,” said Dr. Spencer Pitcher, Co-founder and CEO of Stellarex Energy. “By combining our simplified stellarator approach with UKAEA’s unparalleled fusion expertise, we are significantly de-risking the path to a commercially viable fusion power plant.”

Stephen Wheeler, UKAEA Executive Director, said: “UKAEA has decades of experience operating powerful fusion machines and solving complex fusion challenges that are relevant to many different fusion system designs. We are committed to supporting fusion developers around the globe to help develop fusion as a source of clean energy for tomorrow’s power plants.

“There are many innovative approaches to fusion and UKAEA is pleased to work with Stellarex to support the development of stellarator technology.”

About Stellarex Energy

Stellarex Energy is a Princeton University spin-off focused on fusion energy development. By leveraging a simplified stellarator design, Stellarex Energy reduces technical risk and utilizes staged demonstration devices to validate technology, de‑risk scale‑up, and accelerate the commercial and economical deployment of fusion power. Through its strategic partnership with Ontario Power Generation (OPG) and its leadership in the Centre for Fusion Energy – a new Canadian public-private partnership focused on advancing fusion energy research and developing a demonstration reactor – the company is accelerating the deployment of fusion power in Canada. Stellarex Energy is headquartered in Toronto, Canada.

About the United Kingdom Atomic Energy Authority 

The United Kingdom Atomic Energy Authority (UKAEA) is the UK’s national fusion energy research organisation. We are an executive non-departmental public body of the Department for Energy Security and Net Zero (DESNZ). 

The work we do 

UKAEA’s mission is to lead the delivery of sustainable fusion energy to maximise scientific and UK economic benefit. We do this by being technical experts, partnering with companies and the international research community. At the core of UKAEA’s efforts is the operation of world-leading facilities that build a comprehensive knowledge base for fusion energy. By addressing and solving the challenges across the full lifecycle of fusion, and integrating solutions from various disciplines, we establish technical centres of excellence that serve as the foundation for future fusion power plant programmes. UKAEA collaborates with its partners to develop fusion power plants by providing access to our skills, facilities and expertise. UKAEA owns UK Fusion Energy (UKFE) on behalf of the UK government. Through UKFE, we’re spearheading the Spherical Tokamak for Energy Production (STEP) programme to design and build the UK’s first prototype fusion energy power plant in Nottinghamshire. To grow the fusion ecosystem, UKAEA focuses on cultivating skilled talent, growing the fusion industry and creating ‘innovation clusters’. We actively seek opportunities to advance fusion technologies and communicate its vast potential to stakeholders and the public alike to accelerate fusion energy’s future – the energy of tomorrow we need today. 

For further information, please contact:
Stellarex
info@stellarex.energy

UKAEA Media Relations
mediaenquiry@ukaea.uk

View original content to download multimedia:https://www.prnewswire.com/news-releases/ukaea-and-stellarex-energy-to-advance-fusion-power-development-302770709.html

SOURCE Stellarex, Inc.

SHANGHAI, May 12, 2026 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that, in recognition of its continued efforts and exceptional performance in advancing sustainability, the Company has been included in the 2026 Dow Jones Best‑in‑Class World Index (DJ BIC World) and the Dow Jones Best‑in‑Class Emerging Markets Index (DJ BIC Emerging Markets).

Through S&P Global’s Corporate Sustainability Assessment (CSA), the DJ BIC World Index and the DJ BIC Emerging Markets Index identify sustainability leaders that rank in the top 10% based on their long-term economic, environmental and social performance, selecting from the largest 2,500 global companies in the S&P Global Broad Market Index (BMI) and from the largest 800 companies across 20 emerging markets, respectively.

Based on the 2025 CSA, WuXi Biologics ranked among the top 1% globally within its industry and was included in the S&P Global Sustainability Yearbook for the fourth consecutive year.

Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, commented, “We are honored to be included in both the DJ BIC World Index and the DJ BIC Emerging Markets Index. This recognition reflects our long‑term commitment to sustainability and the continuous enhancement of our overall performance across environmental, social and governance dimensions. As a global leader in Green CRDMO, WuXi Biologics continues to integrate ESG into its business strategy and operations, delivering innovative end‑to‑end solutions to our global partners. Going forward, we will keep pushing industry boundaries, collaborating with all our stakeholders to promote responsible and sustainable practices throughout the entire value chain.”

Over the years, WuXi Biologics’ consistent efforts to promote sustainable development have received notable recognition from leading global ESG rating agencies, including MSCI AAA Ratings; EcoVadis Platinum Medals; “A List” status from CDP for Climate Change, Water Security, and Supplier Engagement Assessment; the highest negligible-risk rating by Morningstar Sustainalytics, and designation as a Sustainalytics industry and regional ESG Leader; inclusion in the FTSE4Good Index Series; a “Prime” designation from ISS ESG Rating; and inclusion in the Hang Seng Corporate Sustainability Benchmark Index.

About WuXi Biologics

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.

With over 13,000 employees in China, the United States, Ireland, Germany, and Singapore — including experts and scientists in biologics R&D and manufacturing, technology innovation, and operational excellence — WuXi Biologics leverages its technologies and expertise to deliver efficient, cost-effective, and scalable biologics solutions tailored to meet clients’ needs. By embedding digital capability and infrastructure across the full biopharmaceutical value chain, the company turns data, computation, and prediction into transparent client experience, faster development, intelligent operations, and more efficient manufacturing. As of December 31, 2025, WuXi Biologics is supporting 945 integrated client projects, including 74 in Phase III and 25 in commercial manufacturing, with complex modalities representing more than half of the entire project portfolio.

WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while demonstrating exemplary Environmental, Social and Governance (ESG) practices. Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts and promote responsible practices that empower the entire value chain.

For more information about WuXi Biologics, please visit: www.wuxibiologics.com

Contacts

Media
PR@wuxibiologics.com 

ESG
esg@wuxibiologics.com 

View original content:https://www.prnewswire.com/news-releases/wuxi-biologics-included-in-2026-dow-jones-bestinclass-world-index-and-emerging-markets-index-302770333.html

SOURCE WuXi Biologics

SHANGHAI, May 12, 2026 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that, in recognition of its continued efforts and exceptional performance in advancing sustainability, the Company has been included in the 2026 Dow Jones Best‑in‑Class World Index (DJ BIC World) and the Dow Jones Best‑in‑Class Emerging Markets Index (DJ BIC Emerging Markets).

Through S&P Global’s Corporate Sustainability Assessment (CSA), the DJ BIC World Index and the DJ BIC Emerging Markets Index identify sustainability leaders that rank in the top 10% based on their long-term economic, environmental and social performance, selecting from the largest 2,500 global companies in the S&P Global Broad Market Index (BMI) and from the largest 800 companies across 20 emerging markets, respectively.

Based on the 2025 CSA, WuXi Biologics ranked among the top 1% globally within its industry and was included in the S&P Global Sustainability Yearbook for the fourth consecutive year.

Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, commented, “We are honored to be included in both the DJ BIC World Index and the DJ BIC Emerging Markets Index. This recognition reflects our long‑term commitment to sustainability and the continuous enhancement of our overall performance across environmental, social and governance dimensions. As a global leader in Green CRDMO, WuXi Biologics continues to integrate ESG into its business strategy and operations, delivering innovative end‑to‑end solutions to our global partners. Going forward, we will keep pushing industry boundaries, collaborating with all our stakeholders to promote responsible and sustainable practices throughout the entire value chain.”

Over the years, WuXi Biologics’ consistent efforts to promote sustainable development have received notable recognition from leading global ESG rating agencies, including MSCI AAA Ratings; EcoVadis Platinum Medals; “A List” status from CDP for Climate Change, Water Security, and Supplier Engagement Assessment; the highest negligible-risk rating by Morningstar Sustainalytics, and designation as a Sustainalytics industry and regional ESG Leader; inclusion in the FTSE4Good Index Series; a “Prime” designation from ISS ESG Rating; and inclusion in the Hang Seng Corporate Sustainability Benchmark Index.

About WuXi Biologics

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.

With over 13,000 employees in China, the United States, Ireland, Germany, and Singapore — including experts and scientists in biologics R&D and manufacturing, technology innovation, and operational excellence — WuXi Biologics leverages its technologies and expertise to deliver efficient, cost-effective, and scalable biologics solutions tailored to meet clients’ needs. By embedding digital capability and infrastructure across the full biopharmaceutical value chain, the company turns data, computation, and prediction into transparent client experience, faster development, intelligent operations, and more efficient manufacturing. As of December 31, 2025, WuXi Biologics is supporting 945 integrated client projects, including 74 in Phase III and 25 in commercial manufacturing, with complex modalities representing more than half of the entire project portfolio.

WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while demonstrating exemplary Environmental, Social and Governance (ESG) practices. Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts and promote responsible practices that empower the entire value chain.

For more information about WuXi Biologics, please visit: www.wuxibiologics.com

Contacts

Media
PR@wuxibiologics.com 

ESG
esg@wuxibiologics.com 

View original content:https://www.prnewswire.com/news-releases/wuxi-biologics-included-in-2026-dow-jones-bestinclass-world-index-and-emerging-markets-index-302770333.html

SOURCE WuXi Biologics

SHANGHAI, May 12, 2026 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that, in recognition of its continued efforts and exceptional performance in advancing sustainability, the Company has been included in the 2026 Dow Jones Best‑in‑Class World Index (DJ BIC World) and the Dow Jones Best‑in‑Class Emerging Markets Index (DJ BIC Emerging Markets).

Through S&P Global’s Corporate Sustainability Assessment (CSA), the DJ BIC World Index and the DJ BIC Emerging Markets Index identify sustainability leaders that rank in the top 10% based on their long-term economic, environmental and social performance, selecting from the largest 2,500 global companies in the S&P Global Broad Market Index (BMI) and from the largest 800 companies across 20 emerging markets, respectively.

Based on the 2025 CSA, WuXi Biologics ranked among the top 1% globally within its industry and was included in the S&P Global Sustainability Yearbook for the fourth consecutive year.

Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, commented, “We are honored to be included in both the DJ BIC World Index and the DJ BIC Emerging Markets Index. This recognition reflects our long‑term commitment to sustainability and the continuous enhancement of our overall performance across environmental, social and governance dimensions. As a global leader in Green CRDMO, WuXi Biologics continues to integrate ESG into its business strategy and operations, delivering innovative end‑to‑end solutions to our global partners. Going forward, we will keep pushing industry boundaries, collaborating with all our stakeholders to promote responsible and sustainable practices throughout the entire value chain.”

Over the years, WuXi Biologics’ consistent efforts to promote sustainable development have received notable recognition from leading global ESG rating agencies, including MSCI AAA Ratings; EcoVadis Platinum Medals; “A List” status from CDP for Climate Change, Water Security, and Supplier Engagement Assessment; the highest negligible-risk rating by Morningstar Sustainalytics, and designation as a Sustainalytics industry and regional ESG Leader; inclusion in the FTSE4Good Index Series; a “Prime” designation from ISS ESG Rating; and inclusion in the Hang Seng Corporate Sustainability Benchmark Index.

About WuXi Biologics

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.

With over 13,000 employees in China, the United States, Ireland, Germany, and Singapore — including experts and scientists in biologics R&D and manufacturing, technology innovation, and operational excellence — WuXi Biologics leverages its technologies and expertise to deliver efficient, cost-effective, and scalable biologics solutions tailored to meet clients’ needs. By embedding digital capability and infrastructure across the full biopharmaceutical value chain, the company turns data, computation, and prediction into transparent client experience, faster development, intelligent operations, and more efficient manufacturing. As of December 31, 2025, WuXi Biologics is supporting 945 integrated client projects, including 74 in Phase III and 25 in commercial manufacturing, with complex modalities representing more than half of the entire project portfolio.

WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while demonstrating exemplary Environmental, Social and Governance (ESG) practices. Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts and promote responsible practices that empower the entire value chain.

For more information about WuXi Biologics, please visit: www.wuxibiologics.com

Contacts

Media
PR@wuxibiologics.com 

ESG
esg@wuxibiologics.com 

View original content:https://www.prnewswire.com/news-releases/wuxi-biologics-included-in-2026-dow-jones-bestinclass-world-index-and-emerging-markets-index-302770333.html

SOURCE WuXi Biologics

DALLAS, May 12, 2026 /PRNewswire/ — Toby Neugebauer, Co-Founder and largest shareholder of Fermi Inc. (d/b/a Fermi America) (Nasdaq: FRMI) (“Fermi” or the “Company”), today responded to the Company threatening to confiscate some of his family shares by announcing that he and his family have decided to gift a percentage of their shares to help the Company solve the 5/50 REIT Rule if and when the Company qualifies as a REIT, to well-deserving foundations and charities. The Neugebauer family, undeterred by threats, believe this is a far better result and are honored to be able to help others in this manner.

A certain time after it becomes a REIT by making the relevant tax election, Fermi would be required to meet the 5/50 Rule, meaning that the Company’s top five shareholders who are individuals cannot hold more than 50% ownership of Fermi. The Neugebauers believe that electing REIT status for 2025 and/or 2026 serves no material tax purpose today. However, the Neugebauers intend to make these supporting gifts to charitable organizations regardless.

Gifting these shares was the Neugebauers’ intention all along. The board’s actions simply accelerated the execution.

Important Information

Mr. Neugebauer and two of his affiliated entities, Vicksburg Investments Management LLC and Melissa A. Neugebauer 2020 Trust (collectively with Mr. Neugebauer, the “Fermi Founder Parties”), together with David A. Daglio, Charles M. Elson, John T. Jimenez and Janet Yang (collectively, in such capacity, the “May 29 Meeting Participants”), intend to file a definitive proxy statement on Schedule 14A, accompanying BLUE proxy card, and other relevant documents with the SEC in connection with the solicitation of proxies with respect to the election of the Fermi Founder Parties’ slate of director candidates and other proposals that may come before the special meeting of shareholder called for May 29, 2026 (the “May 29 Meeting”).

The Fermi Founder Parties and David A. Daglio, Charles M. Elson, John T. Jimenez, Janet Yang, Sheila Hooda and Juan A. Pujadas (collectively, in such capacity, the “Shareholder-Called Special Meeting Participants” and together with the May 29 Meeting Participants, the “Participants”) intend to file a definitive proxy statement on Schedule 14A, accompanying GREEN agent designations card, and other relevant documents with the SEC in connection with the solicitation of proxies with respect to the solicitation of agent designations for calling a special meeting of shareholders anticipated to be held on or around June 30, 2026 (the “Shareholder-Called Special Meeting”).

THE APPLICABLE PARTICIPANTS STRONGLY ADVISE ALL SHAREHOLDERS OF THE COMPANY TO READ THE APPLICABLE DEFINITIVE PROXY STATEMENT AND OTHER PROXY MATERIALS, INCLUDING THE BLUE PROXY CARD AND THE GREEN PROXY CARD, AS APPLICABLE, THAT HAVE BEEN OR WILL BE FILED BY SUCH PARTICIPANTS AS THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE SEC’S WEB SITE AT HTTP://WWW.SEC.GOV. IN ADDITION, THE PARTICIPANTS WILL PROVIDE COPIES OF THE APPLICABLE PROXY STATEMENTS WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST.

The Fermi Founder Parties filed a Schedule 13G with respect to the Company on November 14, 2025, which reported that Mr. Neugebauer beneficially owns 139,016,035 shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), Vicksburg Investments Management LLC beneficially owns 44,656,376 shares of Common Stock, and Melissa A. Neugebauer 2020 Trust beneficially owns 94,359,659 shares of Common Stock. As of the date hereof, none of the other Participants beneficially own any shares of Common Stock.

View original content:https://www.prnewswire.com/news-releases/toby-neugebauer-and-his-family-believe-generosity-is-the-solution-to-meet-550-reit-compliance-should-company-choose-to-unnecessarily-elect-reit-status-for-2025-andor-2026-302770173.html

SOURCE Toby Neugebauer